asurgeryАмбулаторная хирургияAmbulatornaya khirurgiya = Ambulatory Surgery (Russia)2712-87412782-2591ООО «ГРУППА РЕМЕДИУМ»10.21518/akh2024-047asurgery-474Research ArticleЭСТЕТИЧЕСКАЯ МЕДИЦИНА/КОСМЕТОЛОГИЯAESTHETIC MEDICINE/COSMETOLOGYЛазерная коррекция расширенных периорбитальных венLaser treatment of dilated periorbital veinshttps://orcid.org/0000-0002-3940-0787БогачевВ. Ю.BogachevV. Yu.

Богачев Вадим Юрьевич, д.м.н., профессор кафедры факультетской хирургии №2 лечебного факультета; хирург-флеболог, научный руководитель 

117997, Россия, Москва, ул. Островитянова, д. 1

117447, Россия, Москва, ул. Дмитрия Ульянова, д. 31 

Vadim Yu. Bogachev, Dr. Sci. (Med.), Professor of the Department of Faculty Surgery No. 2, Faculty of Medicine; Phlebologist Surgeon, Scientific Supervisor

1, Ostrovityanov St., Moscow, 117997, Russia 

31, Dmitry Ulyanov St., Moscow, 117447, Russia 

vadim.bogachev63@gmail.comhttps://orcid.org/0009-0003-1541-3027ЛобановВ. Н.LobanovV. N.

Лобанов Виктор Николаевич, врач-хирург, сосудистый хирург, генеральный директор 

117447, Россия, Москва, ул. Дмитрия Ульянова, д. 31 

Victor N. Lobanov, Surgeon, Vascular Surgeon, General Director 

31, Dmitry Ulyanov St., Moscow, 117447, Russia 

lobanovic@yandex.ruhttps://orcid.org/0009-0009-1230-1269АбдошР.AbdoshR.

Абдош Робеар, аспирант кафедры факультетской хирургии №2 лечебного факультета 

117997, Россия, Москва, ул. Островитянова, д. 1

Robear Abdosh, Postgraduate Student of the Department of Faculty Surgery No. 2, Faculty of Medicine 

1, Ostrovityanov St., Moscow, 117997, Russia

robear532@gmail.comРоссийский национальный исследовательский медицинский университет имени Н.И. Пирогова; Первый флебологический центрРоссияPirogov Russian National Research Medical University; First Phlebological CenterRussian FederationПервый флебологический центрРоссияFirst Phlebological CenterRussian FederationРоссийский национальный исследовательский медицинский университет имени Н.И. ПироговаРоссияPirogov Russian National Research Medical UniversityRussian Federation202417112024212104110Copyright © Богачев В.Ю., Лобанов В.Н., Абдош Р., 20242024Богачев В.Ю., Лобанов В.Н., Абдош Р.Bogachev V.Y., Lobanov V.N., Abdosh R.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.a-surgeon.ru/jour/article/view/474

Расширенные периорбитальные вены, причиняющие эстетические беспокойства, служат одной из частых причин обращения пациентов в клиники, специализирующиеся в области эстетической флебологии. Этиология и патогенез расширения некогда нормальных вен в области нижних и верхних век, а также височной области точно не изучены. Среди вероятных факторов риска выделяют различные травмы, инвазивные косметологические процедуры, прием препаратов женских половых гормонов, воздействие неблагоприятных факторов окружающей среды, естественное старение кожи, занятие тяжелыми видами спорта и резкую потерю массы тела. Следует отметить, что расширенные периорбитальные вены могут не только причинять беспокойства эстетического характера, но и становиться причиной спонтанных кровоизлияний в окружающие мягкие ткани. Первоначально для коррекции расширенных периорбитальных вен использовали различные варианты склеротерапии или радиочастотную коагуляцию волосковым электродом. В последние годы, благодаря появлению современных лазерных платформ, особенно на алюмоиттриевом гранате, активированном неодимом (Nd:YAG), методом первого выбора в коррекции расширенных вен на лице стала чрескожная лазерная коагуляция (ЧЛК). Современные длинноимпульсные Nd:YAG-лазеры генерируют излучение с длиной волны 1064 нм, обеспечивающей достижение целевых вен, расположенных на разной глубине, а также демонстрирующей высокую тропность к гемоглобину и его производным. Иными словами, для коррекции расширенных вен на лице, в том числе и в периорбитальной зоне, при любых фототипах кожи оптимальным является применение Nd:YAG-лазеров, наиболее удачным представителем которых является многофункциональная платформа для фото- и лазерной терапии XEO (Cutera). В статье представлены клинические случаи успешной коррекции расширенных периорбитальных вен.

Delated periorbital veins causing cosmetic discomfort are one of the most common reasons why patients seek treatment at clinics specializing in aesthetic phlebology. The etiology and pathogenesis of the expansion of once-normal veins on the lower and upper eyelids, as well as in the temporal region have not been established. The potential risk factors include various injuries, invasive cosmetic procedures, intake of female sex hormones, exposure to unfavourable environmental conditions, natural skin ageing, heavy sports activities, and sudden body weight loss. It should be noted that dilated periorbital veins can not only cause aesthetic discomfort, but also induce spontaneous haemorrhages into nearby soft tissues. Initially, dilated periorbital veins were treated using various sclerotherapy options or radiofrequency coagulation with a hair-thin electrode. In recent years, owing to the advent of latest laser platforms, especially neodymium activated yttrium-aluminum-garnet (Nd:YAG) ones, percutaneous laser coagulation (PLC) has become the first-choice technique for treating dilated facial veins. The modern long-pulsed Nd:YAG lasers generate 1064 nm laser radiation, which ensures the achievement of target veins located at different depths under the skin's surface, and also demonstrates high affinity towards haemoglobin and its derivatives. In other words, Nd:YAG lasers are the optimal option to treat dilated facial veins, including those in the periorbital region, in patients with any skin phototypes. The multi-application XEO (Cutera) platform designed for photo and laser therapy is the most successful representative of Nd:YAG lasers. The case reports presented in this article highlight the successful treatment of dilated periorbital veins.

неодимовый лазерпериорбитальные веныфототип кожичрескожная лазерная коагуляцияNd:YAGneodymium-activated laserperiorbital veinsskin phototypepercutaneous laser coagulationNd:YAGReferencesFante RG, Goldman MP. Removal of periocular veins by sclerotherapy. Ophthalmology. 2001;108(3):433–434. https://doi.org/10.1016/s0161-6420(00)00565-0.Fante RG, Goldman MP. Removal of periocular veins by sclerotherapy. Ophthalmology. 2001;108(3):433–434. https://doi.org/10.1016/s0161-6420(00)00565-0.Green D. Removal of periocular veins by sclerotherapy. Ophthalmology. 2001;108(3):442–448. https://doi.org/10.1016/s0161-6420(00)00384-5.Green D. Removal of periocular veins by sclerotherapy. Ophthalmology. 2001;108(3):442–448. https://doi.org/10.1016/s0161-6420(00)00384-5.Bowes LE, Goldman MP. Sclerotherapy of reticular and telangiectatic veins of the face, hands, and chest. Dermatol Surg. 2002;28(1):46–51. https://doi.org/10.1046/j.1524-4725.2002.01154.x.Bowes LE, Goldman MP. Sclerotherapy of reticular and telangiectatic veins of the face, hands, and chest. Dermatol Surg. 2002;28(1):46–51. https://doi.org/10.1046/j.1524-4725.2002.01154.x.Goldman M, Weiss R, Guex JJ, Partsch H, Perrin M, Ramelet AA et al. Sclerotherapy. Treatment of Varicose and Telangiectatic Leg Veins. 6th ed. Elsevier; 2017. 464 p. Available at: https://shop.elsevier.com/books/sclerotherapy/goldman/978-0-323-37726-3.Goldman M, Weiss R, Guex JJ, Partsch H, Perrin M, Ramelet AA et al. Sclerotherapy. Treatment of Varicose and Telangiectatic Leg Veins. 6th ed. Elsevier; 2017. 464 p. Available at: https://shop.elsevier.com/books/sclerotherapy/goldman/978-0-323-37726-3.Богачев ВЮ, Груша ЯО. Первый опыт склерооблитерации поверхностных периорбитальных вен. Флебология. 2010;4(2):17–22. Режим доступа: https://www.mediasphera.ru/issues/flebologiya/2010/2/031997-6976201023.Bogachev VYu, Grusha YaO. The first experience of scleroobliteration of superficial periorbital veins. Flebologiya. 2010;(2):17–22. (In Russ.) Available at: https://www.mediasphera.ru/issues/flebologiya/2010/2/031997-6976201023.Weiss RA, Ramelet AA. Removal of blue periocular lower eyelid veins by ambulatory phlebectomy. Dermatol Surg. 2002;28(1):43–45. https://doi.org/10.1046/j.1524-4725.2002.01189.x.Weiss RA, Ramelet AA. Removal of blue periocular lower eyelid veins by ambulatory phlebectomy. Dermatol Surg. 2002;28(1):43–45. https://doi.org/10.1046/j.1524-4725.2002.01189.x.Vigo RL, Premoli J. Removal of periocular eyelid veins by ambulatory phlebectomy with a regular crochet hook. Ophthalmic Plast Reconstr Surg. 2012;28(3):219–220. https://doi.org/10.1097/IOP.0b013e318249d420.Vigo RL, Premoli J. Removal of periocular eyelid veins by ambulatory phlebectomy with a regular crochet hook. Ophthalmic Plast Reconstr Surg. 2012;28(3):219–220. https://doi.org/10.1097/IOP.0b013e318249d420.Bäumler W, Ulrich H, Hartl A, Landthaler M, Shafirstein G. Optimal parameters for the treatment ofleg veins using Nd:YAG lasers at 1064 nm. Br J Dermatol. 2006;155(2):364–371. https://doi.org/10.1111/j.1365-2133.2006.07314.x.Bäumler W, Ulrich H, Hartl A, Landthaler M, Shafirstein G. Optimal parameters for the treatment ofleg veins using Nd:YAG lasers at 1064 nm. Br J Dermatol. 2006;155(2):364–371. https://doi.org/10.1111/j.1365-2133.2006.07314.x.Railan D, Parlette EC, Uebelhoer NS, Rohrer TE. Laser treatment of vascular lesions. Clin Dermatol. 2006;24(1):8–15. https://doi.org/10.1016/j.clindermatol.2005.10.026.Railan D, Parlette EC, Uebelhoer NS, Rohrer TE. Laser treatment of vascular lesions. Clin Dermatol. 2006;24(1):8–15. https://doi.org/10.1016/j.clindermatol.2005.10.026.Nymann P, Hedelund L, Haedersdal M. Long-pulsed dye laser vs. intense pulsed light for the treatment of facial telangiectasias: a randomized controlled trial. J Eur Acad Dermatol Venereol. 2010;24(2):143–146. https://doi.org/10.1111/j.1468-3083.2009.03357.x.Nymann P, Hedelund L, Haedersdal M. Long-pulsed dye laser vs. intense pulsed light for the treatment of facial telangiectasias: a randomized controlled trial. J Eur Acad Dermatol Venereol. 2010;24(2):143–146. https://doi.org/10.1111/j.1468-3083.2009.03357.x.Srinivas CR, Kumaresan M. Lasers for vascular lesions: standard guidelines of care. Indian J Dermatol Venereol Leprol. 2011;77(3):349–368. https://doi.org/10.4103/0378-6323.79728.Srinivas CR, Kumaresan M. Lasers for vascular lesions: standard guidelines of care. Indian J Dermatol Venereol Leprol. 2011;77(3):349–368. https://doi.org/10.4103/0378-6323.79728.Travelute Ammirati C, Carniol PJ, Hruza GJ. Laser treatment of facial vascular lesions. Facial Plast Surg. 2001;17(3):193–201. https://doi.org/10.1055/s-2001-17973.Travelute Ammirati C, Carniol PJ, Hruza GJ. Laser treatment of facial vascular lesions. Facial Plast Surg. 2001;17(3):193–201. https://doi.org/10.1055/s-2001-17973.Jørgensen GF, Hedelund L, Haedersdal M. Long-pulsed dye laser versus intense pulsed light for photodamaged skin: a randomized splitface trial with blinded response evaluation. Lasers Surg Med. 2008;40(5):293–299. https://doi.org/10.1002/lsm.20634.Jørgensen GF, Hedelund L, Haedersdal M. Long-pulsed dye laser versus intense pulsed light for photodamaged skin: a randomized splitface trial with blinded response evaluation. Lasers Surg Med. 2008;40(5):293–299. https://doi.org/10.1002/lsm.20634.Adamič M, Pavlović MD, Troilius Rubin A, Palmetun-Ekbäck M, Boixeda P. Guidelines of care for vascular lasers and intense pulse light sources from the European Society for Laser Dermatology. J Eur Acad Dermatol Venereol. 2015;29(9):1661–1678. https://doi.org/10.1111/jdv.13177.Adamič M, Pavlović MD, Troilius Rubin A, Palmetun-Ekbäck M, Boixeda P. Guidelines of care for vascular lasers and intense pulse light sources from the European Society for Laser Dermatology. J Eur Acad Dermatol Venereol. 2015;29(9):1661–1678. https://doi.org/10.1111/jdv.13177.Leng M, Zhao H. Cosmetic treatment needs associated with vascular diseases: An emerging future development trend with in aesthetics. Phlebology. 2022;37(10):754–755. https://doi.org/10.1177/02683555221112270.Leng M, Zhao H. Cosmetic treatment needs associated with vascular diseases: An emerging future development trend with in aesthetics. Phlebology. 2022;37(10):754–755. https://doi.org/10.1177/02683555221112270.Gianesini S, Obi A, Onida S, Baccellieri D, Bissacco D, Borsuk D et al. Global guidelines trends and controversies inlower limb venous andlymphatic disease: Narrative literature revision and experts’ opinions following the vWINter international meeting in Phlebology, Lymphology & Aesthetics, 23-25 January 2019. Phlebology. 2019;34(1 Suppl.):4–66. https://doi.org/10.1177/0268355519870690.Gianesini S, Obi A, Onida S, Baccellieri D, Bissacco D, Borsuk D et al. Global guidelines trends and controversies inlower limb venous andlymphatic disease: Narrative literature revision and experts’ opinions following the vWINter international meeting in Phlebology, Lymphology & Aesthetics, 23-25 January 2019. Phlebology. 2019;34(1 Suppl.):4–66. https://doi.org/10.1177/0268355519870690.Major A, Brazzini B, Campolmi P, Bonan P, Mavilia L, Ghersetich I et al. Nd:YAG 1064 nm laser in the treatment of facial andleg telangiectasias. J Eur Acad Dermatol Venereol. 2001;15(6):559–565. https://doi.org/10.1046/j.1468-3083.2001.00354.x.Major A, Brazzini B, Campolmi P, Bonan P, Mavilia L, Ghersetich I et al. Nd:YAG 1064 nm laser in the treatment of facial andleg telangiectasias. J Eur Acad Dermatol Venereol. 2001;15(6):559–565. https://doi.org/10.1046/j.1468-3083.2001.00354.x.Karsai S, Roos S, Raulin C. Treatment of facial telangiectasia using a dual-wavelength laser system (595 and 1,064 nm): a randomized controlled trial with blinded response evaluation. Dermatol Surg. 2008;34(5):702–708. Available at: https://journals.lww.com/dermatologicsurgery/abstract/2008/05000/treatment_of_facial_telangiectasia_using_a.16.aspx.Karsai S, Roos S, Raulin C. Treatment of facial telangiectasia using a dual-wavelength laser system (595 and 1,064 nm): a randomized controlled trial with blinded response evaluation. Dermatol Surg. 2008;34(5):702–708. Available at: https://journals.lww.com/dermatologicsurgery/abstract/2008/05000/treatment_of_facial_telangiectasia_using_a.16.aspx.Bjerring P, Christiansen K, Troilius A. Intense pulsed light source for treatment of facial telangiectasias. J Cosmet Laser Ther. 2001;3(4):169–173. https://doi.org/10.1080/14764170160260744.Bjerring P, Christiansen K, Troilius A. Intense pulsed light source for treatment of facial telangiectasias. J Cosmet Laser Ther. 2001;3(4):169–173. https://doi.org/10.1080/14764170160260744.Bevin AA, Parlette EC, Domankevitz Y, Ross EV. Variable-pulse Nd:YAG laser in the treatment of facial telangiectasias. Dermatol Surg. 2006;32(1):7–12. Available at: https://journals.lww.com/dermatologicsurgery/abstract/2006/01000/variable_pulse_nd__yag_laser_in_the_treatment_of.2.aspx.Bevin AA, Parlette EC, Domankevitz Y, Ross EV. Variable-pulse Nd:YAG laser in the treatment of facial telangiectasias. Dermatol Surg. 2006;32(1):7–12. Available at: https://journals.lww.com/dermatologicsurgery/abstract/2006/01000/variable_pulse_nd__yag_laser_in_the_treatment_of.2.aspx.Ross EV, Uebelhoer NS, Domankevitz Y. Use of a novel pulse dye laser for rapid single-pass purpura-free treatment of telangiectases. Dermatol Surg. 2007;33(12):1466–1469. https://doi.org/10.1111/j.1524-4725.2007.33317.x.Ross EV, Uebelhoer NS, Domankevitz Y. Use of a novel pulse dye laser for rapid single-pass purpura-free treatment of telangiectases. Dermatol Surg. 2007;33(12):1466–1469. https://doi.org/10.1111/j.1524-4725.2007.33317.x.Богачёв ВЮ, Манджикян ОП, Алуханян ОА. Чрескожная лазерная коагуляция расширенных внутрикожных вен: от теории к практике. Амбулаторная хирургия. 2023;20(2):17–26. https://doi.org/10.21518/akh2023-035.Bogachev VYu, Manjikian HP, Alukhanyan OA. Percutaneous laser coagulation of dilated intradermal veins: from theory to practice. Ambulatornaya Khirurgiya. 2023;20(2):17–26. (In Russ.) https://doi.org/10.21518/akh2023-035.Iyer S, Fitzpatrick RE. Long-pulsed dye laser treatment for facial telangiectasias and erythema: evaluation of a single purpuric pass versus multiple subpurpuric passes. Dermatol Surg. 2005;31(8):898–903. https://doi.org/10.1097/00042728-200508000-00002.Iyer S, Fitzpatrick RE. Long-pulsed dye laser treatment for facial telangiectasias and erythema: evaluation of a single purpuric pass versus multiple subpurpuric passes. Dermatol Surg. 2005;31(8):898–903. https://doi.org/10.1097/00042728-200508000-00002.Ozyurt K, Colgecen E, Baykan H, Ozturk P, Ozkose M. Treatment of superficial cutaneous vascular lesions: experience with thelong-pulsed 1064 nm Nd:YAG laser. Scientific World Journal. 2012;2012:197139. https://doi.org/10.1100/2012/197139.Ozyurt K, Colgecen E, Baykan H, Ozturk P, Ozkose M. Treatment of superficial cutaneous vascular lesions: experience with thelong-pulsed 1064 nm Nd:YAG laser. Scientific World Journal. 2012;2012:197139. https://doi.org/10.1100/2012/197139.Sarradet DM, Hussain M, Goldberg DJ. Millisecond 1064-nm neodymium:YAG laser treatment of facial telangiectases. Dermatol Surg. 2003;29(1):56–58. Available at: https://journals.lww.com/dermatologicsurgery/abstract/2003/01000/millisecond_1064_nm_neodymium__yag_laser_treatment.11.aspx.Sarradet DM, Hussain M, Goldberg DJ. Millisecond 1064-nm neodymium:YAG laser treatment of facial telangiectases. Dermatol Surg. 2003;29(1):56–58. Available at: https://journals.lww.com/dermatologicsurgery/abstract/2003/01000/millisecond_1064_nm_neodymium__yag_laser_treatment.11.aspx.Богачев ВЮ, Болдин БВ, Алуханян ОА, Туркин ПЮ, Лобанов ВН. Гиперпигментация после склеротерапии: современные возможности профилактики и лечения. Амбулаторная хирургия. 2023;20(1):81–93. https://doi.org/10.21518/akh2023-012.Bogachev VYu, Boldin BV, Alukhanyan OA, Turkin PYu, Lobanov VN. Hyperpigmentation after sclerotherapy: modern possibilities for prevention and treatment. Ambulatornaya Khirurgiya. 2023;20(1):81–93. (In Russ.) https://doi.org/10.21518/akh2023-012.Богачев ВЮ, Росуховский ДА, Борсук ДА, Шонов ОА, Манджикян ОП, Лобастов КВ и др. Российские клинические рекомендации по диагностике и лечению С1-клинического класса хронических заболеваний вен (ретикулярный варикоз и телеангиэктазии). Амбулаторная хирургия. 2020;(3-4):140–206. https://doi.org/10.21518/18/1995-1477-2020-3-4-140-206.Bogachev VYu, Rosukhovski DA, Borsuk DA, Shonov OA, Manjikian HP, Lobastov KV et al. Russian clinical practice guidelines for the management of C1 clinical class of chronic venous disorders (reticular veins and telangiectasias). Ambulatornaya Khirurgiya. 2020;(3-4): 140–206. (In Russ.) https://doi.org/10.21518/18/1995-1477-2020-3-4-140-206.Eremia S, Li CY. Treatment of face veins with a cryogen spray variable pulse width 1064 nm Nd:YAG Laser: a prospective study of 17 patients. Dermatol Surg. 2002;28(3):244–247. https://doi.org/10.1046/j.1524-4725.2002.01217.x.Eremia S, Li CY. Treatment of face veins with a cryogen spray variable pulse width 1064 nm Nd:YAG Laser: a prospective study of 17 patients. Dermatol Surg. 2002;28(3):244–247. https://doi.org/10.1046/j.1524-4725.2002.01217.x.Carniol PJ, Price J, Olive A. Treatment of telangiectasias with the 532-nm and the 532/940-nm diode laser. Facial Plast Surg. 2005;21(2):117–119. https://doi.org/10.1055/s-2005-872412.Carniol PJ, Price J, Olive A. Treatment of telangiectasias with the 532-nm and the 532/940-nm diode laser. Facial Plast Surg. 2005;21(2):117–119. https://doi.org/10.1055/s-2005-872412.Hercogova J, Brazzini B, Hautmann G, Ghersetich I, Lotti T. Laser treatment of cutaneous vascular lesions: face andleg telangiectases. J Eur Acad Dermatol Venereol. 2002;16(1):12–18. https://doi.org/10.1046/j.1468-3083.2002.00355.x.Hercogova J, Brazzini B, Hautmann G, Ghersetich I, Lotti T. Laser treatment of cutaneous vascular lesions: face andleg telangiectases. J Eur Acad Dermatol Venereol. 2002;16(1):12–18. https://doi.org/10.1046/j.1468-3083.2002.00355.x.Landthaler M, Hohenleutner U. Laser therapy of vascular lesions. Photodermatol Photoimmunol Photomed. 2006;22(6):324–332. https://doi.org/10.1111/j.1600-0781.2006.00254.x.Landthaler M, Hohenleutner U. Laser therapy of vascular lesions. Photodermatol Photoimmunol Photomed. 2006;22(6):324–332. https://doi.org/10.1111/j.1600-0781.2006.00254.x.Dudelzak J, Hussain M, Goldberg DJ. Vascular-specific laser wavelength for the treatment of facial telangiectasias. J Drugs Dermatol. 2009;8(3):227–229. Available at: https://pubmed.ncbi.nlm.nih.gov/19271368/.Dudelzak J, Hussain M, Goldberg DJ. Vascular-specific laser wavelength for the treatment of facial telangiectasias. J Drugs Dermatol. 2009;8(3):227–229. Available at: https://pubmed.ncbi.nlm.nih.gov/19271368/.Bonaparte JP, Ellis DE. Discomfort during Periorbital and Lateral Temporal Laser Vein Treatment: A Double-blind Randomized Controlled Trial. Plast Reconstr Surg Glob Open. 2014;2(5):e159. https://doi.org/10.1097/GOX.0000000000000106.Bonaparte JP, Ellis DE. Discomfort during Periorbital and Lateral Temporal Laser Vein Treatment: A Double-blind Randomized Controlled Trial. Plast Reconstr Surg Glob Open. 2014;2(5):e159. https://doi.org/10.1097/GOX.0000000000000106.

The authors declare that there are no conflicts of interest present.